Ethics approval and consent to participate
ICH
The SELECT-PsA 1 (NCT03104400) and SELECT-PsA 2 (NCT0310437) studies were conducted in accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines, applicable regulations governing clinical trial conduct, and the Declaration of Helsinki 1964 and its later amendments. As per Good Clinical Practice (GCP), the trial protocols were approved by an independent ethics committee (IEC)/institutional review board (IRB). A full list of the IECs and IRBs for SELECT-PsA 1 and SELECT-PsA 2 have been published previously [